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Abstract
Background: Investigating the cellular and molecular signatures in eukaryotic cells following exposure to
nanoparticles will further our understanding on the mechanisms mediating nanoparticle induced effects. This study
illustrates the molecular effects of silver nanoparticles (Ag-np) in normal human lung cells, IMR-90 and human
brain cancer cells, U251 with emphasis on gene expression, induction of inflammatory mediators and the
interaction of Ag-np with cytosolic proteins.
Results: We report that silver nanoparticles are capable of adsorbing cytosolic proteins on their surface that may
influence the function of intracellular factors. Gene and protein expression profiles of Ag-np exposed cells revealed
up regulation of many DNA damage response genes such as Gadd 45 in both the cell types and ATR in cancer
cells. Moreover, down regulation of genes necessary for cell cycle progression (cyclin B and cyclin E) and DNA
damage response/repair (XRCC1 and 3, FEN1, RAD51C, RPA1) was observed in both the cell lines. Double strand
DNA damage was observed in a dose dependant manner as evidenced in gH2AX foci assay. There was a down
regulation of p53 and PCNA in treated cells. Cancer cells in particular showed a concentration dependant increase
in phosphorylated p53 accompanied by the cleavage of caspase 3 and PARP. Our results demonstrate the
involvement of NFB and MAP kinase pathway in response to Ag-np exposure. Up regulation of pro-inflammatory
cytokines such as interleukins (IL-8, IL-6), macrophage colony stimulating factor, macrophage inflammatory protein
in fibroblasts following Ag-np exposure were also observed.
Conclusion: In summary, Ag-np can modulate gene expression and protein functions in IMR-90 cells and U251
cells, leading to defective DNA repair, proliferation arrest and inflammatory response. The observed changes could
also be due to its capability to adsorb cytosolic proteins on its surface.
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Background
Wide spread use of nanoparticles has increased the risk
of nanoparticle induced toxic effects in the environment
and in humans. The rate of exposure increased progres-
sively over the years when engineered nanomaterials
were extensively used in a variety of industries. Inten-
tional manipulation of nanoparticle surfaces with biomo-
lecules and chemicals to cater various applications
resulted in nanomaterials with unforeseeable activity.
Large scale production and improper waste disposal may
elevate human exposure to them and subsequent accu-
mulation of these nanomaterials in nature [1]. To add on
to the complexity, most of the metal nanomaterials seem
t ob en o n - b i o d e g r a d a b l ea n ds u r v i v ei nn a t u r ea n dt i s -
sues for years [2]. Dermal or intravenous injections of
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expose human beings to nanomaterials whose in vivo
activity has not been fully resolved. Recent reports in
nanotoxicology suggest that the interaction and distribu-
tion patterns of these nanomaterials are diverse in differ-
ent cell types [3]. In order to take the full advantage of
nanotechnology, biocompatibility and the toxicology pro-
file of nanoparticles must also be established.
Silver nanoparticles in particular, have attained more
attention and are commonly used in antimicrobial agents
and disinfectants from textiles, medical, pharmaceutical
and electronic industries [4-6]. Rapid commercialisation
of these nanoparticles was boosted by the fallacy that
they are less toxic to cells and tissues than other silver
salts. In reality, silver salts such as silver nitrate (AgNO3)
which release biologically active Ag
+ continually in aqu-
eous media were reported to alter electron transport
chain integrity and metabolic processes [7,8]. We have
previously reported that Ag-np treated cells have limited
exposure to Ag
+ ions as Ag-np solution contained a neg-
ligible amount of free Ag
+ ions [9], despite the potential
release of Ag
+ ions from Ag-np in cell culture. Data sug-
gested that Ag-np and Ag
+ can induce cell death in vitro
through a ROS-mediated apoptotic process [10,11]. Kim
et al [10] reported that Ag
+ induced metal-responsive
metallothionein 1b (MT1b) mRNA expression in AgNO3
treated cells, but not in Ag-np treated cells. Ag
+ also
induced oxidative stress-related glutathione peroxidase 1
(GPx1) and catalase expression to a greater extent than
Ag-np. However, data showed that both Ag
+ and Ag-np
induced comparable superoxide dismutase 1 (SOD1)
expression levels and similar potency in cytotoxicity.
Unanimously, Ag
+ appeared more toxic than Ag-np sug-
gesting that the smaller the particles get the more toxic
they become when the dose is based on mass [9-11].
The proposed mechanism for Ag-np induced toxicity
as shown in our previous study [9] is via mitochondrial
dysfunction, reactive oxygen species release and oxidative
damage. Damage to DNA can be induced through direct
binding of DNA or via oxidative damage to DNA. At cel-
lular level, silver nanoparticles can penetrate cell mem-
brane, be deposited at various organelles, halt cell
proliferation and increase apoptosis. Silver nanoparticles
are also capable of damaging ecosystem as shown in
affecting development of zebrafish embryos [12] and
penetrating plant system [13], causing various chromoso-
mal aberrations to the plant cells. All these reports lack
essential information on the characterisation of nanopar-
ticles employed for the study which will be relevant from
a biological perspective as well. Nanoparticles purchased
from different sources have different stabilising agents
and have uncertain composition and purity. Toxicity of
such nanoparticles varies significantly according to their
material composition and proper characterisation and
accumulation of data could resolve this confusion. Chung
et al have reported that surface modification of Ag-np
with phosphoryl disulphide can greatly lower their cyto-
toxicity [14]. Nadworny et al investigated the protective
and anti inflammatory capacity of Ag-np in porcine skin
dermatitis [15] and in human lymphocytes [16] while
experiments in rats established significant inflammatory
activity [17]. These discrepancies in the nanoparticle
properties demands further investigation on the toxicity
of Ag-np on different human cell types. We have used
human fibroblasts, IMR-90 for this purpose, as they have
diverse functions like wound repair and production of
c y t o k i n e s[ 1 8 ] .T h e ya r ek n o w nt op l a yar o l ei nw o u n d
healing process [19] which makes them a suitable model
for inflammation studies. Fibroblasts are essential cell
types in skin (exposure through contact) and lung tissues
(exposure through inhalation) [19] and hence a suitable
model. Glioblastoma cells, U251 are representative of
cancer cells which are derived from brain tumours. Use
of cancer cells in the study helps not only in understand-
ing the differential response between normal and cancer
cells but also provides useful information on the nano-
particle mediated therapy.
Here, we report a detailed study on the potential mole-
cular mechanisms underlying silver nanoparticle toxicity
using two different cell lines. Specific pathways involved
in silver nanoparticle toxicity were explored. Our results
show that Ag-np could evoke inflammatory response in
cells characterised by high secretion of pro-inflammatory
cytokines, as detected by enzyme linked immuno-sorbent
assay (ELISA). Pathway specific assays focussing on cell
cycle, DNA damage, cell adhesion and extracellular
matrix and cell signalling gave vital information that can
be used to assess the mode of action of Ag-np in cells.
Results
Binding of cytosolic proteins with Ag-np
Isothermal titration calorimetry (ITC) emerged as a
potential tool to explore the binding of DNA, proteins
and amino acids with nanoparticles. A representative
heat change profile for the complexation of cytosolic pro-
teins with starch capped Ag-np and binding of cytosolic
proteins with starch is depicted in Figure 1. Endothermic
nature of the peaks indicates the binding between silver
nanoparticles/starch with proteins. Due to the lack of
exact information on cytosolic proteins such as molecular
weight, concentration of individual proteins in the mix-
ture, and number of moles of surface nanoparticles, bind-
ing isotherms were plotted against total volume of
protein added. It can be seen that a monotonic decrease
in the exothermic heat of binding occurs with successive
injections until saturation is reached. Heat changes
observed during addition of proteins may be due to bind-
ing of nanoparticle or binding of surface starch with
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Page 2 of 14Figure 1 Isothermal titration calorimetry measuring the binding of starch capped silver nanoparticles with cytosolic proteins and pure
starch with cytosolic proteins. (a) binding curves obtained by titration of cytosolic proteins to 1.8 ml of 150 μg starch capped silver
nanoparticles, (b) Calorimetric traces obtained by titration of cytosolic proteins to 1.8 ml of 150 μg of starch, (c) and (d) integral data of the
curves in (a) and (b) respectively plotted as a function of total volume of protein added. (e) Reaction of enthalpy of silver nanoparticles obtained
after subtracting the reaction enthalpy of cytosolic proteins in 150 μg of starch capped silver nanoparticles with cytosolic proteins in 150 μgo f
starch without silver nanoparticles. (f) ITC of silver nanoparticles isothermal titration calorimetry of starch capped silver nanoparticles with
genomic DNA. Integral curves of (e) and (f) are indicated as (g) and (h).
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with pure starch in order to identify their binding with
cytosolic proteins.
Interestingly, ITC curves representing the titration of
cytosolic proteins with starch capped Ag-np can only be
fitted into a model of two sets of binding site (Figure 1a)
while the ITC titration curve representing heat change for
the complexation of cytosolic proteins with starch could
be fitted into a model of a single set binding sites as
depicted in Figure 1b. Integral data of the curves in Figure
1a and 1b are plotted as Figure 1c and 1d as a function of
total volume of protein added to Ag-np and starch, respec-
tively. After subtraction of the binding due to starch and
integration of the corresponding heat changes over time,
generated a typical sigmoidal titration curve as shown in
Figure 1e which strongly support the binding of Ag-np
surface with cytosolic proteins. From the Figure 1f it is
understood that neither starch nor Ag-np were interacting
with genomic DNA. Integral data of the curves in Figure
1e and 1f are plotted as Figure 1g and 1h as a function of
total volume of protein (Figure 1g) and DNA (Figure 1h),
added to Ag-np.
Effect of Ag-np on gene expression
In order to investigate the specific effects of silver nano-
particles on human cells, pathway specific gene expression
profiles for cell cycle, DNA damage, cell adhesion and sig-
nalling cascades were evaluated. To assess the differential
expression in a wider perspective, we have looked at these
effects in both IMR 90 and U251 cells, representatives of
normal cells and cancer cells respectively.
We have earlier demonstrated that Ag-np exposure
affects the cell cycle process in both cells [10]. List of
genes in cell cycle pathway affected by Ag-np exposure
(400 μg/ml) and corresponding expression level changes
are presented in Table 1. CDC2 was the only gene which
showed a significant increase in expression in IMR90 cells,
with a majority of the investigated genes down regulated
(Table 1). U251 cells showed up regulation of CDK5R2,
retinoblastoma (Rb) and Bax gene (Table 1). Gadd 45a in
U251 cells and Gadd 45 g in IMR90 cells were down regu-
lated following exposure to Ag-np (Table 1). We show
that there is a decrease in the protein expression of p53,
p21, PCNA and cyclin B, which are involved in cell cycle
control, following 400 μg/ml Ag-np exposure (Figure 2a,
b). Protein levels for PCNA dropped by a factor of 0.35 in
fibroblasts (Figure 2a) and 0.31 in cancer cells (Figure 2b).
Normal cells showed a 0.32 fold drop in p53 levels
whereas cancer cells exhibited a 0.58 fold decrease. There
was a 0.12 fold drop in p21 levels in normal cells corre-
sponding to 0.72 fold in cancer cells. However, a similar
drop in cyclin B levels in both the cell types (~ 0.41 in nor-
mal cells and 0.42 fold in cancer cells). Low doses of Ag-
np resulted in a gradual decrease in p53 and PCNA levels
(Figure 2a, b) in both the cell lines. p21 showed a concen-
tration dependant decrease in densitometry even though
the protein bands appeared same intensity in control and
in treated with 50 or 200 μg/mL of Ag-np (Figure 2a, b).
The induction of apoptotic pathway is indicated by the
phosphorylation of p53, cleavage of caspase and PARP.
Ag-np exposure induced phosphorylation of p53 in a dose
dependent manner in cancer cells (Figure 2b) but phos-
phorylation was not detected in normal cells (Figure 2a).
Cleavage of Caspase and PARP was observed in both cell
lines (Figure 2a, b). Density of Caspase 3 and PARP frag-
ments were measured and presented in Figure 2a, b. Data
for phospho p53 and proteins involved in apoptosis path-
w a y( C a s p a s ea n dP A R P )a r ed i s p l a y e di nF i g u r e2 a ,b
which showed an increase in Caspase 3 cleavage in both
cell types. Over expression of Caspase 3 was observed spe-
cifically in cancer cells. Normal cells showed up regulation
of PARP but no cleavage. In cancer cells an increase in
Caspase and PARP cleavage was observed along with
increased levels of phospho p53. We have also observed a
decrease in the levels of survivin following Ag-np exposure
in both the cell types.
Analysis of genes involved in DNA damage and repair
pathway showed significant mRNA level changes (Table 2).
U251 and IMR90 cells showed differential profiles in this
pathway after Ag-np exposure. There was an up regulation
of GADD45g in IMR90 cells with rest of the observed
Table 1 Differentially expressed genes in cell cycle
pathway.
IMR 90 U251
Gene Genbank
ID
Fold
change
Gene Genbank
ID
Fold
change
CDC2 NM_001786 24.24 ANAPC2 NM_013366 0.33
CDKN3 NM_005192 -0.67 CDK5R2 NM_003936 4.93
PCNA NM_182649 -0.58 RB1 NM_000321 0.65
SUM01 NM_003352 -0.67 BAX NM_004324 0.96
UBE1 NM_003334 -0.69 CDKN3 NM_005192 -0.87
MCM2 NM_004526 -0.27 CCNE1 NM_001238 -0.55
BIRC5 NM_001168 -0.22 E2F1 NM_005225 -0.75
CCNH NM_001239 -0.27 PCNA NM_182649 -0.78
ANAPC4 NM_013367 -0.51 SUM01 NM_003352 -0.37
KPNA2 NM_002266 -0.37 UBE1 NM_003334 -0.61
CCNB1 NM_031966 -0.91 MCM7 NM_005916 -0.90
RGC32 NM_014059 -0.61 CCNG2 NM_004354 -0.34
CDC20 NM_001255 -0.59 CCNB1 NM_031966 -0.75
CCNE2 NM_057735 -0.40 PKMYT1 NM_182687 -0.34
GADD45A NM_001924 -0.33 CKS1B NM_001826 -0.77
RB1 NM_000321 -0.33 CDC16 NM_003903 -0.21
MKI67 NM_002417 -0.78
MAD2L2 NM_006341 -0.56
Gene expression changes in IMR 90 and U251cells following Ag-np exposure.
All values are normalized against housekeeping genes. Fold change is
calculated as treated/control - 1*. *Basal levels were normalised to 0.
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increase in the major DNA damage repair pathway genes
like, ATM, ATR and XPA. The other important genes in
this pathway like Abl1, Gml, Brca1, Zak, Xrcc5, Trex1,
Pms1, Ccnu and Apex2 were also up regulated in the can-
cer cells. Down regulation of genes involved in base exci-
sion repair (M b d 4 ,A p e x 1 ,O G G 1a n dM u t y h )a n d
mismatch repair pathways (Mutyh, Abl1, Pms1 and MSH2)
were observed. Double strand DNA damage was further
evidenced by the appearance of gH2AX in the nuclei of
Ag-np treated cells (Figure 3a). Untreated U251 cells (Fig-
ure 3b) showed generally less number of foci compared to
cells exposed to 25 μg/mL of Ag-np (Figure 3c), 50 μg/mL
(Figure 3d) 100 μg/mL (Figure 3e) and 10 μMH 2O2
(Figure 3f). Similar pattern was observed in untreated
IMR-90 cells where untreated cells showed no foci (Figure
3g) whereas, exposure with 25 μg/mL of Ag-np (Figure 3h)
50 μg/mL (Figure 3i) 100 μg/mL and (Figure 3j) 10 μM
H2O2 (Figure 3k), showed multiple foci. Quantitative analy-
sis of gH2AX foci assay confirmed that both IMR-90 cells
and U251 cells showed dose dependent increase in gH2AX
foci from 0 to 100 μg/mL. Higher number of foci in U251
cells suggests higher susceptibility of human cancer cells to
Ag-np induced double strand DNA damage (Figure 3a).
Array analyses of cell adhesion and extracellular matrix
showed differential regulation of gene expression. Genes
up regulated and down regulated for the same are listed in
Table 3. Scge (sarcoglycan epsilon) was down regulated in
both cell lines. ITGA2 and Ctnna1 were up regulated in
normal cells treated with Ag-np. Additionally up regula-
tion of integrin was observed in both cells. Transforming
growth factor gene (Tgfbi), Spp1 and ITGA5 were up regu-
lated in cancer cells. Matrix metallo peptidases like MMP3
and MMP2 were slightly upregulated in normal and can-
cer cells respectively.
Key molecules regulating signalling cascades showed up
regulation following Ag-np exposure. Jun, CSF2 and IL-8
showed increased expression in IMR90 cells, whereas,
NFB1, NFBIA, FN1 (fibronectin 1), GADD45A, BIRC2,
TMEPAI (prostate androgen induced RNA) and CEBPB
(CCAAT/enhancer binding protein) were up regulated in
cancer cells (Table 4). Gene data corresponding to cell sig-
nalling are represented in Table 4. Major signalling path-
ways involved in Ag-np mediated molecular response is
Figure 2 Expression profiling of genes involved in cell cycle pathway. Panel (a) represents western blot analysis of selected proteins
showing dose dependant effect of Ag-np in IMR90 and U251 (b) cells. Values for protein levels were obtained by densitometry analysis of X-ray
films using Kodak molecular imaging software and normalized against actin levels to represent accurate values for proteins which deviated from
the control.
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dated by RT-PCR, where an up regulation of IL-8 mRNA
levels in fibroblasts as well as down regulation of p53
(Figure 4a) was observed. MAPK1 mRNA levels were
found to be higher in normal cells (Figure 4b). Exposure
to nanoparticles to cancer cells showed up regulation of
NFB (Figure 4c).
Inflammatory response in nanoparticle mediated cells
The correlation between inflammation and genotoxicity
has been reported earlier [20,21]. Excessive and persistent
formation of reactive oxygen species from inflammatory
cells (neutrophils, macrophages) during particle-elicited
inflammation will generate genetic damage resulting from
the oxidative DNA attack [22]. Conversely, DNA damage
is also capable of inducing the release of inflammatory
cytokines [23,24]. Therefore, it is essential to investigate
the inflammatory properties of Ag-np which can contri-
bute to more thorough understanding on genotoxicity
induced by Ag-np.
Our study to investigate the innate ability of Ag-np to
induce cytokine and chemokines production revealed that
Ag-np triggered production of certain cytokines and inter-
leukins (IL) in normal resting human fibroblasts. Of the
17 cytokines tested, only a few cytokines exhibited detect-
able levels in the supernatant of both Ag-np treated and
untreated cells (Figure 5). There was significant increase in
the production of IL-8, IL-6, ICAM-1, MCP-1, MIP-1b
and GROa in those cells treated with silver nanoparticles
compared to that of untreated control cells (Figure 5).
There was increase in the production of GM-CSF and
IFNg in the silver nanoparticles treated cells. IL1b,I L - 2 ,
IL-7, IL-16, IL-17, TNFa,M I P 1 a and RANTES levels
were not detected in the culture supernatants of both trea-
ted and untreated cells.
Discussion
Interaction of Ag-np with cytosolic proteins
Nanoparticles have a greater tendency to bind with pro-
teins forming a protein corona [25] and mimic nutrients
which facilitate easy receptor mediated uptake. Nano-
particles can also adsorb agonists or antagonists and
interfere with various pathways and truncate the biomo-
lecules [25]. Here, we show that cytosolic proteins are
adsorbed on to silver nanoparticle surface forming a
protein-starch coating which could control cellular
responses. This observation may be useful in the under-
standing of intracellular behaviour of Ag-np. The sur-
face adsorption of protein limit the availability for
cellular functions, but stabilise the proteins thereby inhi-
biting protein degradation in proteasomes [25]. This
process can alter normal cell cycle progression where
timely degradation of proteins is necessary for smooth
transition in to cell cycle stages. Also binding to nano-
particle surface can interfere with native conformation
of the proteins leading to loss of function [25]. Another
outcome of nanoparticle binding is increase in activity
of proteins as a result of immobilisation at surfaces [25].
It is conceivable that the affinity and binding of Ag-np
with proteins vary between cell types that have tissue
specific proteins which explain the altered signalling
pathways operating in different cell types after nanopar-
ticle exposure (MAPK in fibroblasts and NFb in cancer
cells). These results set hurdles on cellular response pre-
diction, as the identity of protein adsorbed to the nano-
particle remains unclear and the fact that the residency
period and choice of protein adsorbed on to these nano-
particles varies with cell and tissue types. It is possible
that Ag-np tends to have different effects on different
cell types. We had reported the nuclear deposition of
Ag-np in zebrafish embryos and human cells (U251)
where Ag-np was seen in the nucleus of cells [12,26].
Considering the property of the nanoparticle surface
which facilitates surface adsorption of proteins, we spec-
ulate that nanoparticles label cytosolic proteins which
require nuclear localisation and are co-transported with
them. Absence of direct interaction with genomic DNA
further supports this notion. This observation has
Table 2 Gene expression pattern in DNA damage
pathway.
IMR-90 U251
Gene Genbank
ID
Fold
change
Gene Genbank
ID
Fold
change
GADD45G NM_006705 6.12 ABL1 NM_005157 1.69
BRCA1 NM_007294 -0.44 GML NM_002066 0.52
ABL1 NM_005157 -0.39 BRCA1 NM_007294 1.89
GML NM_002066 -0.43 ZAK NM_016653 2.54
XRCC5 NM_021141 -0.34 ATR NM_001184 0.21
MSH2 NM_000251 -0.28 XRCC5 NM_021141 0.59
RAD51C NM_058216 -0.74 XPA NM_000380 0.91
ERCC3 NM_000122 -0.73 TREX1 NM_016381 0.51
OGG1 NM_002542 -0.45 PMS1 NM_000534 0.64
XRCC1 NM_006297 -0.31 CCNU NM_021147 1.52
MBD4 NM_003925 -0.59 APEX2 NM_014481 0.29
APEX1 NM_080649 -0.67 ATM NM_000051 1.98
MUTYH NM_012222 -0.49 TP53 NM_000546 -0.28
PMS1 NM_000534 -0.64 FEN1 NM_004111 -0.51
SUMO1 NM_003352 -0.69 RAD51C NM_058216 -0.24
ATM NM_000051 -0.50 PCNA NM_182649 -0.46
CCNH NM_001239 -0.77 RPA1 NM_002945 -0.60
IGHMBP2 NM_002180 -0.50
LIG3 NM_002311 -0.48
APEX2 NM_014481 -0.29
PCNA NM_182649 -0.69
RPA1 NM_002945 -0.53
Regulation of DNA damage response genes in silver nanoparticle treated IMR
90 and U251cells. Fold change is calculated as indicated in table 1.
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nuclear targeting for cancer therapy and transfection.
Effect on gene expression profiles
Our earlier functional studies [26] and current gene
expression data showed that Ag-np exposure induced
cell cycle arrest at S/G2/M phase of cell cycle. This
observation can be due to the changes in the expression
levels of genes regulating the cell cycle process. We
have observed a decrease in the expression of p53, p21,
PCNA, cyclin E and cyclin B. However the cell cycle
arrest seems to be independent of p21 as there was no
inhibition of cdk through p21 induced G1 arrest. Gadd
45 group of proteins are over expressed in cells upon
genotoxic stress [27] was also found to be significantly
elevated in Ag-np treated cells (Gadd 45a in cancer
cells and Gadd 45g in fibroblasts). Gadd 45 regulates
cell cycle by repressing the localization of Cyclin B1 to
the nucleus. This is known to initiate G2/M arrest in
target cells [28]. Cdc 2, a binding partner of cyclin B
proteins was down regulated in both cell types after Ag-
np exposure. Increased Cdc 2 levels may be due to the
accumulation of cells in G2 phase due to the decrease
level of cyclin B seen earlier. Rb and E2F form a repres-
sive complex in S phase, which upon phosphorylation
by cyclin E releases E2F [29]. E2F being the transcrip-
tion factor for S phase genes blocks cell transition
through S phase [29]. We have seen that in cancer cells
Figure 3 Altered gene expression profile in Ag-np treated cells. (a) Quantitative analysis of gH2AX foci showed more double strand DNA
damage induced in U251 cells compared IMR-90 cells. Untreated U251 cells (b) showing minimal foci, (c) cells exposed to 25 μg/mL of Ag-np-3
(d) 50 μg/mL (e) 100 μg/mL and (f) 10 μMH 2O2, showing multiple foci. (g) Untreated IMR90 cells shows no foci whereas, exposure with (h) 25
μg/mL of Ag-np-3 (i) 50 μg/mL (j) 100 μg/mL and (k) 10 μMH 2O2, shows multiple foci.
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the expression of retinoblastoma (Rb) and down regula-
tion of E2F. It is evident that the low levels of cyclin E
could hypo-phosporylate Rb and fail to release E2F ren-
dering them in their repressive forms resulting in S
phase arrest. We have also observed an up regulation of
Zak proteins which are members of Mitogen activated
protein kinase pathway (MAPKKK) that triggers cell
cycle arrest and check point regulation following stress
response. Zak has been associated with down regulation
of cyclin E and S/G2/M arrest [30]. Therefore, we sug-
gest that events like Zak down-regulating cyclin E which
represses E2F and decrease cyclin B levels by Gadd45
resulted in the observed cell cycle arrest. Reports have
already emphasized role of p53 in regulating PCNA and
p21 genes [31]. Hence, down regulation of p53 is
believed to be the reason for low levels of p21 and
PCNA which might play a role in determining the cellu-
lar fate. Along with the down regulation of p53
expression we also observed phosphorylation of residual
p53 in treated cells probably facilitating p53 mediated
effects.
Expression patterns of genes involved in DNA damage
response pathway suggest that cells treated with Ag-np
suffered impaired DNA repair mechanisms in normal
cells and initiation of DNA repair response in cancer
cells. This is evidenced by the increase in ATM and
ATR levels indicating double strand DNA breaks where
they act as sensors activating downstream targets for
DNA repair [32]. Normal cells showed down-regulation
of genes involved in base excision repair (Mbd4, Apex1,
OGG1 and Mutyh), mismatch repair pathways (Mutyh,
Abl1, Pms1 and MSH2) and double strand break repair
pathway (ATM). These molecul a rr e s u l t sf u r t h e rc o n -
firm existing genotoxicity data, where DNA damage and
chromosomal aberrations were observed to be higher in
Ag-np treated U251 cells than IMR-90 [26]. Up regula-
tion of Abl and Brca1 genes specifically in cancer cells
in contrast to that of the normal cells is a significant
observation. DNA repair pathway responsible for DSBs
repair such as homologous recombination (HR) is likely
to be activated with up-regulation of Brca1. Non-homo-
logous end joining (NHEJ), another major DSBs repair
mechanism does not play important role in DSBs repair
in our model as up-regulation of Abl will down-modu-
late NHEJ pathway [33,34]. PCNA is a co factor for
DNA polymerase and an essential player in DNA synth-
esis and DNA repair [35]. Down regulation of PCNA
following Ag-np exposure could have indicated that
repair mechanisms such as base excision repair, nucleo-
tide excision repair and mismatch repair are not essen-
tial in this study as mostly DSBs were induced.
Cell adhesion and extracellular matrix genes were not
highly affected by nanoparticles exposure. However, up
regulations of alpha integrins were observed in both cell
lines. Integrins play vital role in signal transduction and
interactions of cells with extracellular matrix. Up regula-
tion of integrin operates protective mechanisms where
cytoskeletal and ECM are challenged by extraneous fac-
tors [36]. Interestingly, an up regulation of tumour
growth factor or Tgfbi was observed in treated cancer
cells. However, no TGF over expression was detected in
normal cells.
Signalling pathway analysis identified up regulation of
jun in both cell lines which can act through JNK path-
ways regulating cell proliferation or cytokine production.
Involvement of JNK pathway has been reported in silver
nanoparticle mediated toxicity studies [37]. Our experi-
ments unveiled involvement of JNK pathway as over
expression of transcription factor Jun.N F Bi sam a j o r
transcription factors which is a key regulator of immune
survival and anti-apoptotic response. NFB1 and
NFBIA are seen over expressed in cancer cells. A
Table 3 Gene expression changes in cell adhesion and
extracellular matrix pathway.
IMR-90 U251
Gene Genbank
ID
Fold
change
Gene Genbank
ID
Fold
change
ITGA2 NM_002203 2.32 ITGA5 NM_002205 1.55
CTNNA1 NM_001903 1.01 SPP1 NM_000582 1.28
MMP3 NM_002422 0.40 LAMA4 NM_002290 0.24
ITGA11 NM_012211 -0.83 ADAMTS1 NM_006988 0.26
SGCE NM_003919 -0.49 TGFBI NM_000358 1.44
COL6A1 NM_001848 -0.27 SGCE NM_003919 -0.30
LAMA4 NM_002290 -0.27 MMP2 NM_004530 0.29
ADAMTS1 NM_006988 -0.21
Differential expression of genes in IMR-90 and U251 cells are indicated in the
table. All values are normalised against housekeeping genes. Fold change is
calculated as mentioned in table 1.
Table 4 Genes differentially expressed in signal
transduction pathway.
IMR-90 U251
Gene Genbank
ID
Fold
change
Gene Genbank
ID
Fold
change
JUN NM_002228 3.05 FN1 NM_002026 6.76
IL8 NM_000584 21.16 JUN NM_002228 0.35
CSF2 NM_000758 2.82 NFKB1 NM_003998 26.44
TFRC NM_003234 0.64 NFKBIA NM_020529 1.49
BMP2 NM_001200 0.55 BIRC2 NM_001166 3.09
BIRC2 NM_001166 -0.22 GADD45A NM_001924 17.24
IGFBP3 NM_000598 -0.90 TMEPAI NM_020182 10.93
IRF1 NM_002198 -0.30 TFRC NM_003234 1.55
HK2 NM_000189 -0.21 CEBPB NM_005194 10.96
CXCL9 NM_002416 - 0.86
IRF1 NM_002198 -0.21
Fold change is calculated as mentioned in table 1.
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Page 8 of 14significant decrease in the expression of NFBw a s
observed in normal cells following Ag-np exposure. On
the other hand an increase in the expression of MAPK
was observed in normal cells. Jun up regulation was
accompanied by up regulation of pro-inflammatory
cytokine IL-8, granulocyte macrophage colony stimulat-
ing factor (GM-CSF) in normal cells. Similar observa-
tions were reported in carbon nanoparticle toxicity
where IL-8 production was observed to be mediated by
MAPkinase pathway [38]. Another regulator of signal-
ling cascades which was differential expressed is Gadd
45. It is activated by cytokines and signal transduction
pathways like MAPkinase pathway [39]. Once activated,
Gadd 45 can trigger MAPKinase pathway as well.
Up regulation of Bax in cancer cells following Ag-np
exposure, suggested induction of apoptotic stimuli
through mitochondrial pathway. None of the apoptosis
related genes were up regulated in normal cells. Down
regulation of survivin, an apoptosis inhibitor protein
(IAP) that blocks caspases renders it susceptible to
apoptosis. Survivin is over expressed in cancer which
increases resistance to apoptosis [40]. The differential
gene expression profile observed following Ag-np expo-
sure exhibits selective induction of pathways in normal
and cancer cells which will determine the nature of
response to nanoparticle exposure.
Release of pro-inflammatory cytokines from silver
nanoparticles treated fibroblasts
The current investigation shows the ability of silver
nanoparticles to trigger an inflammatory response based
on induction of various pro-inflammatory cytokines and
chemokines. A threefold increase in IL-6 levels was
observed subsequent to exposure with silver nanoparti-
cles. A similar increase in IL-6 levels following silver
nanoparticle exposure recently reported corroborates
with our observation [41]. IL-6, produced by a variety of
cells including fibroblastsi sap l e i o t r o p i cc y t o k i n e
involved in the amplification of inflammatory responses
[42,43]. Rapid increase in IL-6 levels is observed during
Table 5 Summary of major up regulated genes and corresponding pathways involved in Ag-np exposure
Gene (IMR-90) Pathways Genes (U251) Pathways
Jun oncogene
(JUN)
a) Mitogenic Pathway:
b) Wnt Pathway
c) PI3 Kinase/AKT
Pathway
d) Calcium and Protein
Kinase C Pathway
Jun oncogene (JUN) a) Mitogenic Pathway:
b) Wnt Pathway
c) PI3 Kinase/AKT
Pathway
d) Calcium and Protein
Kinase C Pathway
Bone morphogenetic protein 2
(BMP2)
Hedgehog Pathway Fibronectin 1 (FN1) PI3 Kinase/AKT Pathway
Interleukin 8 (IL8)N F B Pathway Nuclear factor of kappa light polypeptide gene
enhancer in B-cells 1 (p105) (NFB1)
NFB Pathway:
Colony stimulating factor 2
(granulocyte-macrophage, CSF2)
a) Calcium and Protein
Kinase C Pathway
b) LDL Pathway
Nuclear factor of kappa light polypeptide gene
enhancer in B-cells inhibitor, alpha(NFBIA)
NFB Pathway
Transferrin receptor (p90, CD71),
(TFRC)
Calcium and Protein
Kinase C Pathway
Transferrin receptor (p90, CD71), (TFRC) Calcium and Protein
Kinase C Pathway
Growth arrest and DNA-damage-inducible, alpha
(GADD45A)
p53 Pathway
CCAAT/enhancer binding protein (C/EBP), beta (CEBPB) Insulin Pathway
Figure 4 mRNA profile as measured by RT-PCR. (a) Elevated levels of IL-8 in IMR90 cells. (b) Increased mRNA levels corresponding to MAPK1
in normal cells. (c) NFB mRNA levels in cancer (U251) cells. Data is represented as mean ± SE from three independent experiments. Statistical
significance was determined between untreated and treated samples using Student’s t test. *p ≤ 0.05.
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Page 9 of 14acute inflammatory responses due to injury, infection
and stress [42,43]. It induces systemic effects affecting
various organs and has been associated with a plethora
of clinical conditions such as inflammatory lung disor-
ders [44] and rheumatoid arthritis [45]. We have
observed an eight fold increase in the levels of interleu-
kin 8, which is also produced by a variety of cells,
including fibroblasts [46]. Inappropriate increase in the
levels of IL-8 has been associated with inflammatory dis-
orders as well [47]. Intercellular adhesion molecule -1
(ICAM-1), MIP-1, MCP-1 (Monocyte chemoattractant
protein - 1) and GRO-alpha known to be up regulated
in inflammatory conditions was also seen following our
silver nanoparticles exposure. These modulate chemo-
taxis, degranulation, phagocytosis and signalling media-
tor synthesis in cells [48,49]. Dysregulation of MIP-1,
MCP-1 and GRO-alpha have been associated with a
variety of inflammatory disorders [50-52]. We also
observed an increase in the levels of GM-CSF and IFNg.
GM-CSF is involved in chemotaxis, phagocytosis and
antigen presentation [53,54]. Increased levels have been
associated with rheumatoid arthritis, chronic obstructive
pulmonary disease and asthma [54]. IFNg responds
against intracellular pathogens and tumour control.
Abnormal expression and protein levels of IFNg have
been associated with autoimmune and inflammatory
conditions [55].
There are reports regarding the anti-inflammatory
effects of silver nanoparticles [15,56,57]. However, the
nature of the study (objectives, experimental conditions
and endpoints) should be taken into consideration.
Most of the studies were conducted on in vivo models
(disease or wound healing models) with pre-existing
injuries and utilized different combinations of silver
nanoparticles coated/impregnated wound dressings. The
objective of these studies was to analyze the additive
therapeutic effects silver nanoparticles can have on the
diseased or injured tissue. Those studies which reported
similar findings using in-vitro studies evaluated the
levels of these cytokines following an addition of a sti-
mulus like LPS while pre or co-incubating with the sil-
ver nanoparticles. Our study was designed to evaluate
the effect of these nanoparticles on normal unstimulated
cells. Moreover, it should be noted that the source of
the nanoparticles, concentration, size, technique and sta-
bilizing agents involved in the preparation will all influ-
ence the response. To summarize, our study clearly
shows an increase in the pro-inflammatory cytokines
specific for human fibroblasts. This can be a unique
response signature in these cells which should be taken
into consideration. Though our study suggests an
inflammatory response following Ag-np exposure, we
cannot rule out the possibility of modifiers such as cell
type used and nanoparticle used in the study.
Ag-np coated medical devices and wound dressings
are already in the market. Human beings are constantly
exposed to such commercial products the biological
properties of which are still elusive. This study sheds
light in to possible side effects of silver nanoparticles
used in cosmetics, household products and in wound
dressings. It is tempting to speculate that Ag-np impreg-
nated wound dressings, catheters and other medical
devices could induce similar response which may have
detrimental effects in vivo as evidenced by the induction
of DNA damage and inflammatory response by Ag-np
in our study.
Conclusion
In summary, the genomics data suggests involvement of
genotoxic stress and subsequent down regulation of DNA
repair pathways in IMR-90 cells and U251 cells. Improper
DNA repair could be a reason for accumulating cells at
Figure 5 Silver nanoparticles induced cytokines and chemokines production in normal human lung fibroblasts (IMR90). The graphs indicate
the production of cytokines and chemokines in pg/ml (mean ± SD) by normal human fibroblasts after incubating with 400 μg/mL of silver
nanoparticles for a period of 48 hours. The cytokine levels were measured in untreated cells (Control) and in cells treated with silver nanoparticles
(treated (Ag-np)). Statistical significance was determined between untreated and treated samples using Student’s t test. *p value ≤ 0.05.
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Page 10 of 14S/G2/M phases of the cell cycle. Ag-np is able to down
regulate many proteins involved in cell cycle progression
and DNA repair by preventing their degradation possibly
by surface adsorption. Ag-np can activate a variety of
pathways including MAPK and NFB pathways resulting
in transcription of many genes involved in proliferation
and inflammatory response. Our findings also suggest that
only a small population of cells are undergoing apoptosis
while majority are alive and were undergoing proliferation
arrest. Our data reveal that Ag-np toxicity could trigger a
detrimental inflammatory response. A more in-depth and
multi parametric studies are recommended to elucidate
the diverse role and effects of nanoparticles on different
types of human cells including cancer cells. Such studies
will further facilitate accurate toxicological profiling of
nanoparticles and their potential therapeutic use in the
management of different pathological conditions in
humans.
Methods
Nanoparticles employed in this study (6-20 nm) were
synthesised and characterised by us as described in our
previous reports [26,58]. Extensive characterisations of
the particles have been done through electron micro-
scopy, dynamic light scattering and UV-visible
spectroscopy.
Cell culture and nanoparticle exposure
Normal human lung fibroblasts (IMR-90) were pur-
chased from Coriell cell repositories, USA. Cells were
maintained in Minimum Essential Medium (MEM, Invi-
trogen, NY USA) supplemented with 15% foetal bovine
serum (Hyclone, USA), 2% essential amino acids and 1%
each of non-essential amino acid, vitamins and penicil-
lin-streptomycin (GIBCO, Invitrogen, USA). The cells
(passage 14 ± 2) were grown at 37°C in the presence of
5% CO2 at log phase. Human glioblastoma cells were
received from Dr. Masao Suzuki, National Institute of
Radiological Sciences, Chiba, Japan and were maintained
in Dulbecco’s modified Eagles medium (DMEM, Sigma-
Aldrich, MO, USA) supplemented with 10% foetal
bovine serum (FBS, GIBCO, Invitrogen, USA) and 1%
penicillin streptomycin (Gibco, Invitrogen, NY, USA).
Stock solutions were prepared in ultrapure water by dis-
solving 5 mg of silver nanoparticles in 1 mL of ultra
pure water. A uniform suspension was prepared by
sonication.
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) computes the
kinetics of molecular interactions based on the thermo-
dynamics in the reaction. The interaction between the
ligand and the binding partners is measured through
subtle heat changes occurring in the reaction chamber.
The system consists of an injector, sample chamber and
a reference cell. The ligand is injected at regular inter-
vals into the chamber containing the second molecule.
T h es a m p l ec h a m b e ra n dt h er e f e r e n c ec e l l sa r ek e p ta t
constant temperature. The binding between the ligand
and the partner can either release or absorb heat.
Endothermic (absorbs heat) reactions will prompt the
system to provide heat in order to maintain the standard
temperature in relation to the reference cell, whereas an
exothermic reaction initiate absorption of excess heat by
the system to stabilize the temperature. Heat changes
per injections will be used to assess the interaction
and calculate the binding affinity between the molecules.
ITC experiments were carried out using a VP-ITC titra-
tion calorimetric system (Microcal Inc., MA, USA) oper-
ated at 25°C. Each microcalorimetric titration experiment
consisted of 60 successive injections of a constant volume
(5 μL/injection) of cytosolic protein (300 μg) in water to
the reaction cell containing (150 μgi n1 . 8m L )A g - n p .
The binding of starch to protein solutions in the absence
of Ag-np and binding of starch capped Ag-np with geno-
mic DNA was determined, using the same number of
injections and concentration of proteins/DNA as in the
titration experiments. Data analysis was carried out with
Origin 7.0 software supplied with the instrument.
Messenger RNA isolation and array hybridisation
C e l l sw e r es e e d e da tad e n s i t yo f2×1 0
6 cells/T75 flasks
and treated with 400 μg/mL of Ag-np for 48 hours. Cells
were harvested in cold 1 × phosphate buffered saline (PBS,
1
st Base, Singapore) and mRNA was isolated using Qiagen
RNeasy mini kit (Qiagen, Hilden, Germany), following
manufacturer’s instruction. The concentration and integ-
rity of mRNA was tested using Nanodrop spectrophot-
ometer (Thermo Fischer Scientific, USA). The RNA from
untreated and nanoparticle treated cells were used for
hybridisation. The arrays (Oligo GEArray; SuperArray
Bioscience Corporation, MD, USA) employed were
human cell cycle oligo GEArray (OHS-020), human DNA
damage signalling pathway oligo GEArray (OHS-029),
human signal transduction pathway finder oligo GEArray
(OHS-014) and human extracellular matrix and adhesion
molecules oligo GEArray (OHS-013). Probing was done as
per manufacturer’s instructions. Briefly, complementary
RNA (cRNA) was synthesised using TrueLabeling-AMP
Linear RNA Amplification Kit (SuperArray Bioscience
Corporation, Frederick, MD) as per manufacturer’s
instructions and biotinylated using Biotin-16-uridine-5’-
triphosphate (Roche, Germany). The biotinylated cRNA (3
mg) was used for overnight hybridisation at 60°C. The
membrane was treated with alkaline phosphatase conju-
gated to streptavidin. Treated membranes were exposed to
chemiluminescence reagent and image was captured on
X- ray films. Image analysis was performed using GEArray
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tion, MD, USA). Normalisation was carried out using
Rps27a, Gapdh, B2m, Hsp90ab1 and Beta actin. All values
were normalised against housekeeping genes. Fold change
is calculated as treated/control - 1. Basal levels were nor-
malised to 0 instead of 1.
Real-time Reverse Transcriptase Polymerase Chain
Reaction (RT-PCR)
RT-PCR was used to validate the results from array. RT-
PCR was done using LightCycler
® RNA Amplification Kit
SYBR Green I (Roche, Germany). Probes were designed
using primer design utility. The details of genes employed
and annealing temperature (TA) are included in Table 6.
DNA strands were amplified by denaturation at 95°C for
30 seconds followed by annealing of primers at specific
temperatures for 15 seconds. Extension of the strands was
done for 1 min at 72°C. The experiments were conducted
three times independently.
Western blotting
Cells density and exposure were maintained similar to
array experiments. Cells were scraped and washed with
cold 1 × PBS. Protein was isolated by lysing the cells on
ice for 20 min with radio immuno precipitation buffer
(RIPA, 100 μL). The protein was isolated by centrifugation
at 12,000 rpm for 1 hr at 4°C and quantified using Brad-
ford assay kit with bovine serum albumin (BSA) standards
(Biorad laboratories, CA, USA). Proteins (40 μg) were
separated in 10% poly-acrylamide gel and blotted on to
nitrocellulose membrane (Hybond ECL, Amersham bios-
ciences, UK), blocked in 5% non-fat milk and incubated
with primary antibodies (monoclonal anti mouse antibo-
dies) against PCNA (dilution 1:800), cyclin B1 (1:1000),
p21 (1:500), p53 (1:2000) phosphorylated p53 (phospho
p53, cell signalling technologies Inc, Danvers, MA, USA
1:1000), PARP (1:1000) survivin (1:500), caspase 3 (1:500),
and beta actin (Chemicon international, Temecula, CA,
USA 1:5000). All antibodies were purchased from Santa
Cruz biotechnologies Inc (Santa Cruz, CA, USA) unless
stated otherwise. Goat anti-mouse antibody tagged with
horseradish peroxidase (Immuno pure, Pierce biotechnol-
ogies, Rockford, IL, USA, 1:5000) was used as secondary
antibodies. Protein bands were visualized by chemilumi-
nescence (ECL, Amersham biosciences, UK) and exposed
to X-ray films (Pierce biotechnologies, Rockford, IL, USA).
The intensity of bands was analysed using Kodak molecu-
lar imaging software (Kodak, USA) and normalised against
actin. The normalised values were used for comparison
with array data. Additional experiments were done using
selected proteins (PCNA, cyclin B, p53, p21, caspase 3,
PARP) for Ag-np concentrations 50 and 200 μg/mL, to
explore dose dependant effects.
Immunofluorescence staining for gH2AX
Phosphorylation of histone H2AX occurs following a dou-
ble strand DNA break, where ATM/ATR is activated. The
phosphorylated protein binds to the DNA, at the damage
site, aiding the repair process, which can be used as a bio-
marker for detecting ds DNA damage. The cells were pla-
ted on cover slips (0.4 million cells/well) in 6-well plates
and treated with the nanoparticles (25, 50 and 100 μg/mL
of Ag-np-3; 80 and 160 μg/mL of Pt-np) for 2 hrs. Cells
exposed to 10 μMH 2O2 were used as positive controls.
Following incubations, the cover slips were washed in PBS
twice and fixed in 4% formaldehyde for 15 min. After
washing away excess formaldehyde, the cells were permea-
bilised in 0.2% triton × solution, blocked in 5% BSA (1 hr)
and incubated in primary Anti-phospho histone gH2AX
mouse monoclonal antibody (Ser 139, JBW 103, Upstate
biotechnology Inc., USA) for 1 hr. The cover slips were
washed thrice in PBS to remove excess of primary anti-
body and stained with secondary antibody (anti-mouse
antibody conjugated to FITC, eBiosciences, USA) for 1 hr.
After washing away the excess of secondary antibodies,
the cover slips were mounted in DAPI-vectashield. The
images were captured under the DAPI-FITC filter of Zeiss
Axioplan microscope. The experiment was repeated three
Table 6 Primer sequences and conditions employed in RT-PCR
Gene Primer sequence TA (°C)
p53 5’GGC CCA CTT CAC CGT ACT AA3’
5’GTG GTT TCA AGG CCA GAT GT3’
60
Mitogen activated protein
kinase (MAPK1)
5’CCA CCC ATA TCT GGA GCA GT3’
5’CAG TCC TCT GAG CCC TTG TC 3’
60
Interleukin-8 (IL-8) 5’ATG ACT TCC AAG CTG GCC GTG GCT 3’
5’TCT CAG CCC TCT TCA AAA ACT TCT C 3’
61
Nuclear factor beta (NFB) 5’ AGT TGA GGG GAC TTT CCC AGG 3’
5’ GCC TGG GAA AGT CCC CTC AAC T 3’
61
18s Ribosomal subunit 5’ GTA ACC CGT TGA ACC CCA TT-3’
5’ CCA TCC AAT CGG TAG TAG CG 3’
60
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Page 12 of 14times. Fifty DAPI-stained nucleus per sample were cap-
tured randomly with Zeiss Axioplan 2 imaging fluores-
cence microscope equipped with appropriate filters.
Number of foci on each cell was recorded.
Cytokine detection assay
The effect of Ag-np on the levels of cytokines and che-
mokines of human lung fibroblasts were determined by
collecting the supernatants from both the untreated and
silver nanoparticles treated cultures were collected and
stored in -80°C until used. The cytokines were quanti-
fied using Bio-Plex™ Cytokine assay (Bio-Rad Labora-
tories, CA, USA). Premixed multiplex beads of the Bio-
Plex human cytokine panel, which included 17 cytokines
of choice (IL-1b, IL-2, IL-4, IL-6, IL-7, IL-8, IL-16, IL-
17, TNFa,I F N g, MCP-1 (CCL2), MIP-1a (CCL3), MIP-
1b, RANTES, ICAM-1, GM-CSF, GROa) were used and
the assay was performed thrice by strictly adhering to
the manufacturer’s instructions. The data were analysed
using the Bio-Plex Manager 4.0 software (Bio-Rad
Laboratories, CA, USA).
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